Induction of Stable Chimerism for Sickle Cell Anemia

NCT00029393 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Blood Disease
Hematopoietic Stem Cell Transplantation
Anemia, Sickle Cell

Interventions

PROCEDURE: Hematopoietic Stem Cell Transplantation
DRUG: Immunosuppression

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)